182 related articles for article (PubMed ID: 28090485)
21. Mixed-phenotype acute leukemia: historical overview and a new definition.
Weinberg OK; Arber DA
Leukemia; 2010 Nov; 24(11):1844-51. PubMed ID: 20844566
[TBL] [Abstract][Full Text] [Related]
22. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
Bene MC; Castoldi G; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer MB
Leukemia; 1995 Oct; 9(10):1783-6. PubMed ID: 7564526
[TBL] [Abstract][Full Text] [Related]
23. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
[TBL] [Abstract][Full Text] [Related]
24. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
25. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
[TBL] [Abstract][Full Text] [Related]
26. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing.
Quesada AE; Hu Z; Routbort MJ; Patel KP; Luthra R; Loghavi S; Zuo Z; Yin CC; Kanagal-Shamanna R; Wang SA; Jorgensen JL; Medeiros LJ; Ok CY
Oncotarget; 2018 Feb; 9(9):8441-8449. PubMed ID: 29492206
[TBL] [Abstract][Full Text] [Related]
27. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity.
Galera P; Dilip D; Derkach A; Chan A; Zhang Y; Persuad S; Mishera T; Liu Y; Famulare C; Gao Q; Mata DA; Arcila M; Geyer MB; Stein E; Dogan A; Levine RL; Roshal M; Glass J; Xiao W
medRxiv; 2023 Nov; ():. PubMed ID: 37961275
[TBL] [Abstract][Full Text] [Related]
30. The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China.
Ding B; Zhou L; Jiang X; Li X; Zhong Q; Wang Z; Yi Z; Zheng Z; Yin C; Cao R; Liao L; Meng F
Dis Markers; 2015; 2015():382186. PubMed ID: 25944974
[TBL] [Abstract][Full Text] [Related]
31. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
32. Oddballs: acute leukemias of mixed phenotype and ambiguous origin.
Steensma DP
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1235-53. PubMed ID: 22093585
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?
Rossi JG; Rubio P; Alonso CN; Bernasconi AR; Sajaroff EO; Digiorge J; Baialardo E; Eandi-Eberle S; Guitter M; Fernandez-Barbieri A; Mitchell R; Felice MS
Leuk Res; 2018 Aug; 71():6-12. PubMed ID: 29935384
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
[TBL] [Abstract][Full Text] [Related]
35. Haematological profile of patients with mixed-phenotype acute leukaemia from a tertiary care centre of north India.
Sharma M; Sachdeva MUS; Bose P; Varma N; Varma S; Marwaha RK; Malhotra P
Indian J Med Res; 2017 Feb; 145(2):215-221. PubMed ID: 28639598
[TBL] [Abstract][Full Text] [Related]
36. Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.
Zając-Spychała O; Irga-Jaworska N; Drożyńska E; Muszyńska-Rosłan K; Krawczuk-Rybak M; Zawitkowska J; Kowalczyk J; Ćwiklińska M; Balwierz W; Mizia-Malarz A; Badowska W; Kamieńska E; Urasiński T; Kaczorowska A; Kazanowska B; Chybicka A; Wysocki M; Sędek Ł; Szczepański T; Woszczyk M; Matysiak M; Młynarski W; Karolczyk G; Chaber R; Wachowiak J
Eur J Haematol; 2020 Jul; 105(1):85-93. PubMed ID: 32223036
[TBL] [Abstract][Full Text] [Related]
37. Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia.
Ikeda M; Nakahara W; Asako M; Umeki Y; Matsuoka Y; Terakawa T; Matsunaga H; Iwasa Y; Saito R; Iwama Y; Matsui T; Oka K; Ueda S
Case Rep Hematol; 2023; 2023():3628712. PubMed ID: 36879893
[TBL] [Abstract][Full Text] [Related]
38. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
Alexander TB; Orgel E
Curr Oncol Rep; 2021 Feb; 23(2):22. PubMed ID: 33544265
[TBL] [Abstract][Full Text] [Related]
39. Optimal therapeutic strategies for mixed phenotype acute leukemia.
Wolach O; Stone RM
Curr Opin Hematol; 2020 Mar; 27(2):95-102. PubMed ID: 31913151
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
Cheng J; Klairmont MM; Choi JK
Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
